Kaplan, Nachum and Simon, Melvin I. (1988) Purification and characterization of the wild-type and mutant carboxy-terminal domains of the Escherichia coli Tar chemoreceptor. Journal of Bacteriology, 170 (11). pp. 5134-5140. ISSN 0021-9193 http://resolver.caltech.edu/CaltechAUTHORS:KAPjbact88
See Usage Policy.
Use this Persistent URL to link to this item: http://resolver.caltech.edu/CaltechAUTHORS:KAPjbact88
The carboxy-terminal half of the Escherichia coli Tar chemoreceptor protein was cloned into an overproducing plasmid with the transcription of the insert under the control of the strong hybrid tac promoter. Two dominant mutations in the tar gene, which result in "tumble-only" (tar-526) or "swim-only" (tar-529) phenotypes and which are postulated to produce proteins locked in specific signalling modes, were introduced separately onto the overproducing plasmid. After induction with isopropyl-beta-D-thiogalactopyranoside, cells containing the plasmids produced about 10% of their soluble cellular protein as the carboxy-terminal fragments. A scheme to purify the overproduced fragments was developed. Typical yields of pure fragment were 5, 30, and 20 mg per liter of induced culture for the wild type, 526 mutant, and 529 mutant, respectively. Fast-protein liquid chromatography-gel filtration analysis of the pure fragments showed that they all existed as oligomers (ca. 103,000 daltons), possibly trimers or tetramers (monomer size is 31,000 daltons). However, the 529 mutant fragment showed an additional oligomeric form (240,000 daltons) corresponding approximately to an octamer. When chromatographed in the presence of 1% octylglucoside, all three fragments showed an identical single oligomeric size of about 135,000 daltons. Further differences between the fragments such as ion-exchange behavior and susceptibility to degradation were found. Taken together, these results suggest that conformational differences between the 529 mutant fragment and the other fragments exist and that these differences may correlate with the phenotypic effects of the tar-529 mutation.
|Additional Information:||Copyright © 1988 by the American Society for Microbiology. Received 2 November 1987/Accepted 12 August 1988 This work was supported by a Public Health Service grant A119296-06 from the National Institutes of Health. We thank Lyn Williams, Microchemical Facility, Norton Cancer Center, Medical School, University of Southern California, Los Angeles, for performing the N-terminal amino acid sequencing. We also thank J. S. Remington for his hospitality and K. Oosawa for his indispensable advice. N.K. was a recipient of a Chaim Weitzman Postdoctoral Fellowship.|
|Usage Policy:||No commercial reproduction, distribution, display or performance rights in this work are provided.|
|Deposited By:||Archive Administrator|
|Deposited On:||18 Dec 2006|
|Last Modified:||26 Dec 2012 09:24|
Repository Staff Only: item control page